+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11



Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11



Head and Neck 37(11): 1625-1632



Recurrent respiratory papillomatosis (RRP) is mainly associated with human papillomavirus (HPV)6 or HPV11. The purpose of this study was to compare clinical outcome, aggressiveness, and treatment response between HPV6- and HPV11-associated RRP. A retrospective cohort of 55 patients with RRP (1974-2012) was used. Surgical interventions (n = 814) were analyzed, and complications scored. HPV6/11-specific polymerase chain reaction (PCR) was performed on RRP biopsies. Seventy-six percent of patients (42 of 55) were infected with HPV6 and 24% (13 of 55) with HPV11. The HPV11 group had anatomically more widespread disease. The expected number of surgical interventions was higher in the younger age (<22.4 years) HPV11 group, and the older age (<22.4 years) HPV6 group. Regardless of HPV type, earlier age of onset of RRP resulted in a higher number of surgical interventions. Anatomically, HPV11-associated RRP behaves more aggressively. Younger patients with HPV11 and older patients with HPV6 experience a worse clinical course of RRP.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052113726

Download citation: RISBibTeXText

PMID: 24955561

DOI: 10.1002/hed.23808


Related references

Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatric and Developmental Pathology 4(1): 68-72, 2001

Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil. Auris, Nasus, Larynx 2018, 2018

Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. Journal of Clinical Microbiology 35(12): 3098-3103, 1997

Detection of human papillomavirus in the upper respiratory tract in children without recurrent respiratory papillomatosis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 47(12): 974-977, 2014

The heterogeneous distribution of human papillomavirus activities in recurrent respiratory papillomatosis. Journal of Investigative Medicine 43(SUPPL 1): 1A, 1995

Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe. International Journal of Pediatric Otorhinolaryngology 116: 147-152, 2018

Human papillomavirus infection in recurrent upper respiratory tract papillomatosis. Archiv fuer Geschwulstforschung 60(6): 429-434, 1990

Divergent human papillomavirus associated with recurrent respiratory papillomatosis with lung involvement. Genome Announcements 1(4), 2013

Detection and cloning of human papillomavirus DNA associated with recurrent respiratory papillomatosis in Thailand. Japanese Journal Of Cancer Research. 85(7): 699-703, 1994

Molecular identification of 7 human papillomavirus types in recurrent respiratory papillomatosis. Archives of Otolaryngology--Head and Neck Surgery 126(9): 1119-1123, 2000

Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia. Head and Neck 35(2): 229-234, 2013

Comparison of the AdvanSure human papillomavirus screening real-time PCR, the Abbott RealTime High Risk human papillomavirus test, and the Hybrid Capture human papillomavirus DNA test for the detection of human papillomavirus. Annals of Laboratory Medicine 32(3): 201-205, 2012

Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. Apmis 118(6-7): 455-470, 2010

Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis. Laryngoscope 2019, 2019

Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus. Pediatric Infectious Disease Journal 27(2): 149-154, 2008